On November 6, 2025, federal officials announced agreements with manufacturers of branded GLP-1 medications that significantly reduce prices under a new direct-to-consumer platform known as TrumpRx
This convergence of demographic shifts, urbanization patterns, and elevated health awareness is establishing Asia Pacific as a structural growth engine for the glutathione market, with sustained momentum expected across the forecast period
about the effect of GLP-1s beyond weight and metabolism to addictions, menopausal health, autoimmune diseases, and even mental health
They flag lab abnormalities that could stem from nutritional deficiencies
That said, a major barrier to achieving widespread adoption lies in affordability according to our survey, 45% of current patients cite cost as one of the primary reasons for discontinuing their medication
Subscribe to stay up to date with the latest news and tips GLP-1 medications cost up to $1,000 monthly without insurance coverage, creating barriers to weight loss and diabetes treatment for millions of patients